Vascular endothelial growth factor C complements the ability of positron emission tomography to predict nodal disease in lung cancer

Plasma levels of VEGF-C complemented the ability of PET to predict nodal disease among patients with suspected or confirmed NSCLC. VEGF-D did not improve prediction.